Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Aethon Therapeutics

Request full access

A company creating custom antibody therapeutics that unite immunotherapy and targeted therapy

New York City, United StatesFounded 2022Biotech & Life Sciences

About Aethon Therapeutics

Aethon Therapeutics is a pioneering biotechnology company focused on developing advanced treatments for drug-resistant cancer. The company engineers novel antibodies designed to be used in combination with targeted therapies, aiming to selectively eradicate cancer cells that have become resistant to conventional treatments. Operating in the life sciences sector, Aethon Therapeutics collaborates with leading research institutions like NYU Langone Health to drive innovation in cancer treatment. The business model revolves around the development and commercialization of these specialized antibodies, generating revenue through partnerships, licensing agreements, and direct sales to healthcare providers. By integrating targeted and immune therapies, Aethon Therapeutics aims to transform cancer treatments into potential cures, offering hope to patients with limited options.

Source: Dealroom company data

At a glance

Status
Operational
Employees
16
Open positions
1
Dealroom signal
44.1/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2023 $30M $120M NYU Langone Health · Apple Tree Partners ↗
SPINOUT✓Other financing Jan 2022 $0 — NYU Langone Health —
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Aethon Therapeutics website traffic

Latest recorded traffic for Aethon Therapeutics is 4K monthly website visits, up 66.7% over the last three months. Aethon Therapeutics's team grew 6.7% over the past year.

Latest monthly visits4K 3-month web change+66.7% 1-year team growth+6.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom
1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Aethon Therapeutics in the New York City ecosystem

Live from Dealroom

The Aethon Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

  • Apple Tree Partners
  • NYU Langone Health
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Aethon Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Aethon Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.